Avantor (AVTR) Liabilities and Shareholders Equity (2018 - 2026)

Avantor's (AVTR) quarterly Liabilities and Shareholders Equity came in at $11.7 billion in Q1 2026, down 5.38% year-on-year from $12.3 billion in Q1 2025, and down 1.12% quarter-over-quarter from $11.8 billion in Q4 2025.

Avantor (AVTR) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

Avantor's Liabilities and Shareholders Equity history runs 9 years deep, the most recent figure standing at $11.7 billion for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 5.38% year-over-year to $11.7 billion in Q1 2026; TTM through Mar 2026 was $47.9 billion, a 4.13% decrease from a year earlier, with the FY2025 full-year figure at $11.8 billion, down 2.64% from the prior year.
  • Liabilities and Shareholders Equity retreated to $11.7 billion in Q1 2026 per AVTR's latest filing, from $11.8 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $13.8 billion in Q1 2022 and bottomed at $5.3 billion in Q4 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $12.8 billion (2024), against an average of $11.9 billion.
  • Across the five-year window, Liabilities and Shareholders Equity soared 103.38% in 2024 and fell 9.07% in 2025, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $5.3 billion in 2022, then climbed by 13.4% to $6.0 billion in 2023, then surged by 103.38% to $12.1 billion in 2024, then slipped by 2.64% to $11.8 billion in 2025, then retreated by 1.12% to $11.7 billion in 2026.
  • Per Business Quant, the three latest AVTR Liabilities and Shareholders Equity figures stand at $11.7 billion (Q1 2026), $11.8 billion (Q4 2025), and $11.7 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Intuitive Surgical 126.32 Bn 121.10 Bn 1.96 Bn 20.88 Bn
2 Becton Dickinson 44.69 Bn 43.88 Bn 2.15 Bn 50.83 Bn
3 Alcon 32.80 Bn 31.14 Bn 1.53 Bn 31.62 Bn
4 Medline 32.72 Bn 30.49 Bn 1.84 Bn 39.01 Bn
5 Resmed 29.54 Bn 27.88 Bn 890.98 Mn 8.78 Bn
6 West Pharmaceutical Services 23.56 Bn 23.13 Bn 329.20 Mn 4.08 Bn
7 Solventum 14.00 Bn 13.44 Bn 1.10 Bn 14.10 Bn
8 Cooper Companies 13.75 Bn 13.61 Bn 735.40 Mn 12.48 Bn
9 Align Technology 12.03 Bn 10.97 Bn 736.59 Mn 6.31 Bn
10 Avantor 8.00 Bn 7.72 Bn 500.70 Mn 11.66 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.66 Bn
Dec 31, 2025 11.79 Bn
Sep 30, 2025 11.68 Bn
Jun 30, 2025 12.78 Bn
Mar 31, 2025 12.33 Bn
Dec 31, 2024 12.11 Bn
Sep 30, 2024 12.84 Bn
Jun 30, 2024 12.69 Bn
Mar 31, 2024 12.76 Bn
Dec 31, 2023 5.96 Bn
Sep 30, 2023 12.80 Bn
Jun 30, 2023 13.06 Bn
Mar 31, 2023 13.40 Bn
Dec 31, 2022 5.25 Bn
Sep 30, 2022 13.11 Bn
Jun 30, 2022 13.43 Bn
Mar 31, 2022 13.84 Bn
Dec 31, 2021 4.86 Bn
Sep 30, 2021 12.20 Bn
Jun 30, 2021 11.25 Bn